ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 671765 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 671765; 2) Community: the network communities that were significantly associated with the response to NSC 671765; 3) Molecule: the relationships between components within communities and NSC 671765; 4) MDR: the compounds that were significantly associated with the NSC 671765.

NSC Compound Enrichment Correlation
NSC 606499 Camptothecin Derivative 0.0378615809326464 0.079190723
NSC 625502 Antimony, chlorobis(4-morpholinecarbodithioato-S,S')-, 0.0378615809326464 0.48940864
NSC 626162 Discorhabdin C . TFA 0.0378615809326464 0.38638034
NSC 631136 Benzoxazole, 2-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.0378615809326464 0.20905187
NSC 633113 [1,2,3,4]Tetrathiocino[5,6-d:7,8-d']diimidazole- 2,9-dithione, 1,3,8,10-tetraethyl-1,2,3,8,9,10-hexahydro- 0.0378615809326464 0.34225362
NSC 633207 Null 0.0378615809326464 0.39200769
NSC 633271 Null 0.0378615809326464 0.23387771
NSC 639514 Cyclopentanone, 2-[(dimethylamino)methyl]-5- [[4-[(propionyloxy)methoxy]phenyl]methylene]-, hydrochloride 0.0378615809326464 0.33001903
NSC 639520 Cyclohexanone, 2-[(2-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.0378615809326464 0.22836235
NSC 642968 Benzo[g]quinoline-5,10-dione, 5,10-dihydro- 4-[2-(1-piperidinyl)ethenyl]- 0.0378615809326464 0.25701068
Total:130  Current:103    [First] [Prev] [Next] [Last]